Uncategorized
Biosimilars new approach

Biosimilars new approach

1
Clearly define all your risks up front
2
Understand interactions between multiple hazards
3
Consider using simulation studies to conduct drug product operational qualification
4
Write it all down in a validation master plan focused on your cold chain processes